DEPARTMENT FOR BUSINESS, ENERGY & INDUSTRIAL STRATEGY
A randomized trial to evaluate the toxicity and efficacy of 1200mg and 1800mg rifampicin daily for 4 months in the treatment of pulmonary tuberculosis
IATI Identifier: GB-GOV-13-FUND--GCRF-MR_N006127_1